Credit: S. Bradbrook/NPG

Autophagy is the process through which intracellular components are targeted to lysosomes for degradation and recycling — it is essential for maintaining cellular homeostasis, particularly during infection or metabolic stress. Two complementary studies describe a crucial role for autophagy in regulating cellular metabolism in regulatory T (TReg) cells and T helper 2 (TH2) cells. Interestingly, defective autophagy impairs survival and lineage stability in peripheral TReg cells but leads to expansion of TH2 cell populations in a cell-intrinsic manner.

Wei et al. found that peripheral TReg cells show higher autophagy activity compared with naive CD4+ T cells. They generated mice with a TReg cell-specific deletion of the essential autophagy-related 7 (Atg7) gene (Foxp3CreAtg7fl/fl mice) and found that these animals developed lymphoid hyperplasia by 3 months of age and had increased proportions of effector/memory T cells compared with controls. Effector/memory T cells from Foxp3CreAtg7fl/fl mice produced aberrantly high levels of interferon-γ (IFNγ) and interleukin-17 (IL-17), and the animals developed severe systemic inflammation by 5 months of age. Compared with controls, Foxp3CreAtg7fl/fl mice had lower proportions of TReg cells in the spleen, lymph nodes and, in particular, the colon but normal proportions of thymic TReg cells. Similar phenotypes were observed in mice with a TReg cell-specific deletion of Atg5, another essential autophagy gene.

Further analyses showed that ATG7 is not essential for TReg cell proliferation but instead promotes their survival and lineage stability. ATG7-deficient TReg cells showed higher rates of apoptosis and a failure to maintain FOXP3 expression, which was associated with the upregulation of IFNγ and other inflammatory cytokines. Autophagy maintained TReg cell stability and survival partly by restraining mTOR complex 1 (mTORC1) activity following TReg cell activation through T cell receptors or other stimulatory pathways. Aberrant mTORC1 activity in ATG7-deficient TReg cells was associated with increased MYC expression and heightened glycolytic metabolism; pharmacological blockade of MYC or glycolysis partially restored lineage stability in these cells. Furthermore, activated TReg cells were more sensitive to apoptosis than quiescent TReg cells in response to autophagy deficiency. Therefore, autophagy preferentially supports the survival and lineage stability of activated TReg cells.

Kabat et al. examined how the inflammatory bowel disease (IBD)-associated gene autophagy-related 16-like 1 (Atg16l1) affects intestinal T cell responses. They generated mice with a CD4+ T cell-specific deletion of Atg16l1 (Atg16l1ΔCD4 mice) and found that these animals developed splenomegaly, lymphadenopathy and chronic intestinal pathology by 5 months of age. Younger Atg16l1ΔCD4 mice had lower T cell counts in peripheral lymphoid organs and the intestine compared with controls, but developed exacerbated disease in a model of IBD. Closer analysis showed that young Atg16l1ΔCD4 mice had decreased numbers of TH1 and TH17 cells, and reduced peripheral TReg cell counts (particularly in the intestine) but had higher TH2 cell numbers. In keeping with this, ageing Atg16l1ΔCD4 mice developed an aberrant type 2 antibody response against dietary antigens and commensal bacteria.

The authors found that TReg cells from Atg16l1ΔCD4 mice showed intrinsic survival defects, whereas TH2 cells from these animals showed comparable or improved survival in relation to wild-type controls. Experiments in which Atg16l1ΔCD4 mice were reconstituted with wild-type TReg cells indicated that ATG16L1 regulates TH2 cell expansion through a cell-intrinsic mechanism, rather than indirectly through TReg cell loss. Kabat et al. next generated mice with a TReg cell-specific deletion of Atg16l1 (Foxp3CreAtg16l1fl/fl mice); in agreement with the findings by Wei et al., these animals developed a severe spontaneous systemic inflammation by 5 months of age that was associated with impaired survival and lineage stability of peripheral TReg cells. Also in keeping with the study by Wei et al., Kabat et al. found that ATG16L1-deficient TReg cells showed augmented glycolytic activity; this was most apparent in intestinal TReg cells. The authors noted that TH2 cells have enhanced glycolytic metabolism compared with TReg cells under homeostatic conditions and propose that this accounts for why TH2 cells are more resistant to the metabolic consequences of blocking autophagy.

drugs targeting autophagy could be useful for manipulating peripheral CD4+ T cell responses in the clinic

These studies suggest that drugs targeting autophagy could be useful for manipulating peripheral CD4+ T cell responses in the clinic — indeed, in a mouse tumour model, Wei et al. observed that Foxp3CreAtg7fl/fl mice have reduced tumour cell growth owing to defective TReg cell function at the tumour site.